240 likes | 323 Views
Evaluating Capacity/Collaboration Building Efforts Not as Easy as You Think! The Gestational Diabetes Collaborative National Association of Chronic Disease Directors Program Integration Teleconference September 12, 2011. National Collaborators. CDC Division of Diabetes Translation
E N D
Evaluating Capacity/Collaboration Building EffortsNot as Easy as You Think!The Gestational Diabetes CollaborativeNational Association of Chronic Disease DirectorsProgram Integration TeleconferenceSeptember 12, 2011
National Collaborators CDC Division of Diabetes Translation CDC Division of Reproductive Health Association of Maternal and Child Health Programs (AMCHP) National Association of Chronic Disease Directors (NACDD) NACDD Women’s Health and Diabetes Councils
What Is the Goal of This Project? To foster integration (collaboration) of MCH and chronic disease programs in the development of diabetes prevention initiatives
Objectives of this Project Discover connections between maternal health and chronic disease prevention across the lifespan, especially for women of child-bearing age (15-44). Articulate lessons learned from maternal and child health (MCH) and chronic disease initiatives that focus on diabetes prevention among women of child-bearing age. Understand the maternal and infant complications associated with GDM and particularly, the increased risk of developing Type 2 diabetes among women with a history of GDM).
Objectives continued • Share information about existing state data sources that can monitor: ◦prevalence of GDM ◦prevalence of type 2 diabetes among women ages 15-44 years ◦risk factors for GDM and type 2 diabetes such as obesity, inactivity, family history of diabetes, and previous birth of an infant >4000 grams. • Develop a state action plan to prevent or delay the development of Type II diabetes among women who have a history of GDM. • Identify and prioritize at least three possible strategies for MCH and chronic disease program collaboration to address critical issues in gestational diabetes data collection, diagnosis, treatment and follow-up
Objectives continued Engage in teambuilding to develop the plan for action Identify and address factors that promote or hinder MCH and chronic disease collaborations List potential partners (internal and external) to assist in collaboration Participate in a capacity assessment survey at baseline and 12 months later
Methods 1 ½ day workshop on collaboration Baseline and follow-up assessments after 12 months Zoomerang assessments completed independently by MCH and Chronic Disease Directors States: Missouri, Ohio, West Virginia
Assessment Design Three Sections I. MCH and CD Collaboration II. GDM Competencies III. Capacity for reducing Type 2 Diabetes among women with hx of GDM
Likert Scale • Assigned points to Scale: 1 = Strongly disagree 2 = Disagree 3 = Neutral 4 = Agree 5 = Strongly agree
I: Networking/Cooperation Participate on committees together Have constructive work relationships Are committed to the GDM collaboration Seek opportunities to collaborate Support each others’ program’s efforts Keep appointments with one another
I. Coordination/Resource Sharing Share data and information of mutual interest Proactively coordinate on assignments of common interest Regularly meet about programming
I. Policy Development, Planning, and Decision-Making Invite participation of one another when developing messaging, marketing, or packaging of promotional materials Share accountability and credit for joint initiatives’ successes Jointly plan analyses and publications Share resources to expand services Jointly develop funding applications Jointly develop policy around women’s health issues Make decisions together to further enhance women’s health issues
II. Knowledge/Ability Association between GDM and development of Type 2 diabetes Key overlapping chronic disease and MCH issues related to GDM and diabetes prevention Evidence-based approaches to GDM management, prevention and control Current scientific evidence for GDM/diabetes prevention programs and practices GDM/diabetes prevention initiatives for different populations
II. Data Identify appropriate data sources relevant to GDM/diabetes prevention initiatives Use data to identify and monitor GDM and diabetes burden, trends, and outcomes among women Use data to develop recommendations for changes in policy, programs, data collection, and practice. Use data to develop and prioritize intervention strategies for GDM/diabetes prevention initiatives Use MCH and Diabetes program evaluation findings to improve GDM/diabetes prevention initiatives
III. Funding Dedicated funding for GDM initiatives Funding for staff training related to GDM initiatives Budget for medical supplies or equipment related to GDM initiatives Budget for promoting GDM initiatives
III. Staffing Dedicated staff time for GDM program integration efforts Commitment to GDM program integration efforts GDM programmatic knowledge, training, and skills Adequate time to monitor program activities Ability to effectively build support with management Access to program evaluation expert consultation on GDM initiatives
III. Effective Leadership Leadership support for MCH and CD collaboration and integration in general Leadership support for developing or enhancing current GDM activities to prevent Type 2 Diabetes Adequate oversight/management of GDM integrated efforts Mentoring/technical assistance for GDM integrated efforts GDM Program integration is a priority for leadership Has a GDM master plan and effective communication of that vision
III. Internal Administrative Systems Integrated data collection and surveillance systems Compatible administrative system across their programs Compatible information technology and computer systems across programs Coordinated management systems across programs Communication networks and tools facilitate information sharing
Preliminary Results Overall, there was increased capacity and collaboration for GDM work between baseline and at the 12-month follow-up
Next Steps Due to staff changes in one state, the assessments were completed by different people at baseline and follow-up, necessitating interviews with each state team member for validation of results After validation and further analysis, results will be published and available
Contact Information Joan Ware, Consultant National Assoc. of Chronic Disease Directors 801-277-2353 ware@chronicdisease.org